• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病发病机制细胞模型中多巴胺与α-突触核蛋白相互作用的蛋白质组学分析。

Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.

机构信息

Department of Structural and Functional Biology, University of Insubria, Busto Arsizio, Italy.

出版信息

FEBS J. 2010 Dec;277(23):4909-19. doi: 10.1111/j.1742-4658.2010.07896.x. Epub 2010 Oct 26.

DOI:10.1111/j.1742-4658.2010.07896.x
PMID:20977677
Abstract

Altered dopamine homeostasis is an accepted mechanism in the pathogenesis of Parkinson's disease. α-Synuclein overexpression and impaired disposal contribute to this mechanism. However, biochemical alterations associated with the interplay of cytosolic dopamine and increased α-synuclein are still unclear. Catecholaminergic SH-SY5Y human neuroblastoma cells are a suitable model for investigating dopamine toxicity. In the present study, we report the proteomic pattern of SH-SY5Y cells overexpressing α-synuclein (1.6-fold induction) after dopamine exposure. Dopamine itself is able to upregulate α-synuclein expression. However, the effect is not observed in cells that already overexpress α-synuclein as a consequence of transfection. The proteomic analysis highlights significant changes in 23 proteins linked to specific cellular processes, such as cytoskeleton structure and regulation, mitochondrial function, energetic metabolism, protein synthesis, and neuronal plasticity. A bioinformatic network enrichment procedure generates a significant model encompassing all proteins and allows us to enrich functional categories associated with the combination of factors analyzed in the present study (i.e. dopamine together with α-synuclein). In particular, the model suggests a potential involvement of the nuclear factor kappa B pathway that is experimentally confirmed. Indeed, α-synuclein significantly reduces nuclear factor kappa B activation, which is completely quenched by dopamine treatment.

摘要

多巴胺稳态的改变是帕金森病发病机制中的一个公认机制。α-突触核蛋白的过度表达和处置受损促成了这一机制。然而,与细胞溶质多巴胺和增加的α-突触核蛋白相互作用相关的生化改变仍不清楚。儿茶酚胺能 SH-SY5Y 人神经母细胞瘤细胞是研究多巴胺毒性的合适模型。在本研究中,我们报告了多巴胺暴露后过表达α-突触核蛋白(诱导 1.6 倍)的 SH-SY5Y 细胞的蛋白质组学模式。多巴胺本身能够上调α-突触核蛋白的表达。然而,在由于转染而过表达α-突触核蛋白的细胞中,没有观察到这种效应。蛋白质组学分析强调了与特定细胞过程相关的 23 种蛋白质的显著变化,如细胞骨架结构和调节、线粒体功能、能量代谢、蛋白质合成和神经元可塑性。生物信息学网络富集程序生成了一个包含所有蛋白质的显著模型,并允许我们富集与本研究中分析的因素组合相关的功能类别(即多巴胺与α-突触核蛋白)。特别是,该模型表明核因子 kappa B 途径可能参与其中,这一点通过实验得到了证实。事实上,α-突触核蛋白显著降低了核因子 kappa B 的激活,而多巴胺处理则完全抑制了这种激活。

相似文献

1
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.帕金森病发病机制细胞模型中多巴胺与α-突触核蛋白相互作用的蛋白质组学分析。
FEBS J. 2010 Dec;277(23):4909-19. doi: 10.1111/j.1742-4658.2010.07896.x. Epub 2010 Oct 26.
2
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.多巴胺促进人神经母细胞瘤 SH-SY5Y 细胞中α-突触核蛋白寡聚化。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):129-34. doi: 10.1016/j.bbrc.2009.11.015. Epub 2009 Nov 11.
3
Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.多巴胺转运体介导的6-羟基多巴胺体外细胞毒性取决于与帕金森病相关的突变α-突触核蛋白的表达。
Neurochem Int. 2006 Apr;48(5):329-40. doi: 10.1016/j.neuint.2005.11.008. Epub 2006 Jan 6.
4
Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors.胰岛素样生长因子对α-突触核蛋白细胞毒性的挽救作用。
Biochem Biophys Res Commun. 2009 Jul 31;385(3):434-8. doi: 10.1016/j.bbrc.2009.05.089. Epub 2009 May 24.
5
G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.G 蛋白偶联受体激酶 5 在帕金森病的 α-突触核蛋白上调模型中过表达,调节 bcl-2 的表达。
Brain Res. 2010 Jan 11;1307:134-41. doi: 10.1016/j.brainres.2009.10.036. Epub 2009 Oct 21.
6
Alpha-synuclein and Parkinson's disease: a proteomic view.α-突触核蛋白与帕金森病:蛋白质组学视角
Expert Rev Proteomics. 2008 Apr;5(2):239-48. doi: 10.1586/14789450.5.2.239.
7
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.大鼠黑质中α-突触核蛋白的过表达导致多巴胺能神经元丧失、α-突触核蛋白磷酸化及半胱天冬酶-9激活:类似于帕金森病的致病变化。
J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x.
8
A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease.一种用于筛选具有帕金森病治疗潜力化合物的基于细胞的α-突触核蛋白病模型。
Acta Pharmacol Sin. 2007 May;28(5):616-26. doi: 10.1111/j.1745-7254.2007.00539.x.
9
Phosphorylation of α-synuclein upregulates tyrosine hydroxylase activity in MN9D cells.α-突触核蛋白的磷酸化可上调 MN9D 细胞中酪氨酸羟化酶的活性。
Acta Histochem. 2011 Jan;113(1):32-5. doi: 10.1016/j.acthis.2009.07.007. Epub 2009 Aug 14.
10
Controlling the mass action of alpha-synuclein in Parkinson's disease.控制帕金森病中α-突触核蛋白的质量作用
J Neurochem. 2008 Oct;107(2):303-16. doi: 10.1111/j.1471-4159.2008.05612.x. Epub 2008 Sep 2.

引用本文的文献

1
Efficacy of herbal medicine treatment based on syndrome differentiation for Parkinson's disease: A systematic review and meta-analysis of randomized placebo-controlled clinical trials.基于辨证论治的中药治疗帕金森病的疗效:随机安慰剂对照临床试验的系统评价和荟萃分析
Front Pharmacol. 2023 Feb 27;14:1108407. doi: 10.3389/fphar.2023.1108407. eCollection 2023.
2
Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models.用尿酸预处理间充质干细胞可增强帕金森病模型中的神经保护特性。
J Tissue Eng. 2021 Mar 30;12:20417314211004816. doi: 10.1177/20417314211004816. eCollection 2021 Jan-Dec.
3
Parkin interacts with Mitofilin to increase dopaminergic neuron death in response to Parkinson's disease-related stressors.
帕金蛋白与线粒体外膜转位酶相互作用,以增加多巴胺能神经元在帕金森病相关应激源作用下的死亡。
Am J Transl Res. 2020 Nov 15;12(11):7542-7564. eCollection 2020.
4
Neuroprotective effects of genistein on SH-SY5Y cells overexpressing A53T mutant α-synuclein.金雀异黄素对过表达A53T突变型α-突触核蛋白的SH-SY5Y细胞的神经保护作用。
Neural Regen Res. 2018 Aug;13(8):1375-1383. doi: 10.4103/1673-5374.235250.
5
The Mechanisms of Traditional Chinese Medicine Underlying the Prevention and Treatment of Parkinson's Disease.中医药防治帕金森病的作用机制
Front Pharmacol. 2017 Sep 19;8:634. doi: 10.3389/fphar.2017.00634. eCollection 2017.
6
New insight into neurodegeneration: the role of proteomics.神经退行性变的新见解:蛋白质组学的作用。
Mol Neurobiol. 2014 Jun;49(3):1181-99. doi: 10.1007/s12035-013-8590-8. Epub 2013 Dec 10.
7
Role of Ser129 phosphorylation of α-synuclein in melanoma cells.α-突触核蛋白 Ser129 磷酸化在黑素瘤细胞中的作用。
J Cell Sci. 2013 Jan 15;126(Pt 2):696-704. doi: 10.1242/jcs.122093. Epub 2012 Nov 30.
8
Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology.α-突触核蛋白的替代转录本在帕金森病病理中的作用机制。
Nat Commun. 2012;3:1084. doi: 10.1038/ncomms2032.
9
The proteome of the locus ceruleus in Parkinson's disease: relevance to pathogenesis.帕金森病蓝斑核的蛋白质组学:与发病机制的相关性。
Brain Pathol. 2012 Jul;22(4):485-98. doi: 10.1111/j.1750-3639.2011.00540.x. Epub 2011 Nov 8.
10
Alterations in glutathione S-transferase pi expression following exposure to MPP+ -induced oxidative stress in the blood of Parkinson's disease patients.帕金森病患者血液中 MPP+ 诱导的氧化应激后谷胱甘肽 S-转移酶 pi 表达的改变。
Parkinsonism Relat Disord. 2011 Dec;17(10):765-8. doi: 10.1016/j.parkreldis.2011.06.026. Epub 2011 Aug 12.